Japan’s Risk Management Plan Will Require Tinkering To New Drug Applications
This article was originally published in PharmAsia News
Executive Summary
New rules take effect April 2013, but uncertainty remains within the PMDA and industry on how RMP guidance will evolve and shape development in the years ahead.